https://www.nasdaq.com/press-release/adaptive-biotechnologies-to-present-virtually-at-the-40th-annual-j.p.-morgan
https://www.nasdaq.com/press-release/adaptive-biotechnologies-announces-new-data-demonstrating-the-benefit-of-serial-mrd
https://www.nasdaq.com/press-release/adaptive-biotechnologies-and-collaborators-to-present-more-than-30-abstracts-on
https://www.nasdaq.com/press-release/adaptive-biotechnologies-receives-updated-medicare-coverage-for-its-minimal-residual
https://www.nasdaq.com/press-release/adaptive-biotechnologies-reports-third-quarter-2021-financial-results-2021-11-03
https://www.nasdaq.com/press-release/adaptive-biotechnologies-to-report-third-quarter-financial-results-on-november-3-2021
https://www.nasdaq.com/press-release/adaptive-biotechnologies-presents-new-data-during-idweek-demonstrating-the-capability
https://www.nasdaq.com/press-release/adaptive-biotechnologies-launches-enhanced-clonoseqr-assay-reports-for-patients-with
https://www.nasdaq.com/press-release/adaptive-biotechnologies-announces-grand-opening-of-state-of-the-art-headquarters-and
https://www.nasdaq.com/press-release/adaptive-biotechnologies-to-present-new-sars-cov-2-data-from-its-immune-medicine
https://www.nasdaq.com/press-release/adaptive-biotechnologies-to-present-at-the-morgan-stanley-global-healthcare
https://www.nasdaq.com/press-release/curebase-adaptive-biotechnologies-announce-collaboration-to-expand-clinical-study
https://www.nasdaq.com/press-release/adaptive-biotechnologies-appoints-nitin-sood-as-chief-commercial-officer-2021-08-04
https://www.nasdaq.com/press-release/adaptive-biotechnologies-reports-second-quarter-2021-financial-results-2021-08-04
https://www.nasdaq.com/press-release/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021
https://www.nasdaq.com/press-release/new-study-published-in-nature-provides-further-evidence-that-covid-19-vaccine-induced
https://www.nasdaq.com/press-release/adaptive-biotechnologies-included-in-more-than-20-abstracts-at-asco-and-eha-2021
https://www.nasdaq.com/press-release/adaptive-biotechnologies-to-participate-in-upcoming-june-2021-investor-conferences
https://www.nasdaq.com/press-release/adaptive-biotechnologies-reports-first-quarter-2021-financial-results-2021-05-05
https://www.nasdaq.com/press-release/adaptive-biotechnologies-to-present-at-the-bofa-securities-2021-virtual-healthcare
https://www.nasdaq.com/press-release/adaptive-biotechnologies-to-report-first-quarter-financial-results-on-may-5-2021-2021
https://www.nasdaq.com/press-release/adaptive-biotechnologies-strengthens-expertise-and-diversity-of-board-of-directors
https://www.nasdaq.com/press-release/adaptive-biotechnologies-announces-fda-emergency-use-authorization-for-t-detecttm
https://www.nasdaq.com/press-release/adaptive-biotechnologies-to-present-at-the-cowen-41st-annual-healthcare-conference
https://www.nasdaq.com/press-release/adaptive-biotechnologies-reports-fourth-quarter-and-full-year-2020-financial-results
https://www.nasdaq.com/press-release/adaptive-biotechnologies-expands-collaboration-with-labcorp-to-increase-access-to
https://www.nasdaq.com/press-release/adaptive-biotechnologies-launches-t-detecttm-covid-first-clinical-t-cell-based-test
https://www.nasdaq.com/press-release/adaptive-biotechnologies-to-report-fourth-quarter-and-full-year-2020-financial
https://www.nasdaq.com/press-release/adaptive-biotechnologies-to-collaborate-with-astrazeneca-in-mapping-the-immune
https://www.nasdaq.com/press-release/adaptive-biotechnologies-to-present-at-the-39th-annual-j.p.-morgan-healthcare
https://www.nasdaq.com/press-release/adaptive-biotechnologies-announces-new-clinical-data-demonstrating-impact-of
https://www.nasdaq.com/press-release/adaptive-biotechnologies-and-collaborators-to-present-data-from-more-than-35
https://www.nasdaq.com/press-release/preliminary-data-from-real-world-study-demonstrate-t-cell-testing-outperforms
https://www.nasdaq.com/press-release/adaptive-biotechnologies-announces-collaboration-with-gsk-to-measure-minimal-residual
https://www.nasdaq.com/press-release/adaptive-biotechnologies-reports-third-quarter-2020-financial-results-2020-11-10
https://www.nasdaq.com/press-release/adaptive-biotechnologies-to-report-third-quarter-financial-results-on-november-10
https://www.nasdaq.com/press-release/adaptive-biotechnologies-to-present-at-the-morgan-stanley-2020-healthcare-conference
https://www.nasdaq.com/press-release/adaptive-biotechnologies-reports-second-quarter-2020-financial-results-2020-08-10
https://www.nasdaq.com/press-release/adaptive-biotechnologies-to-present-at-the-ubs-genomics-2.0-and-medtech-innovations
https://www.nasdaq.com/press-release/adaptive-biotechnologies-receives-expanded-fda-clearance-for-the-clonoseqr-assay-to
https://www.nasdaq.com/press-release/adaptive-biotechnologies-launches-immunoseq-t-map-covid-first-molecular-t-cell
https://www.nasdaq.com/press-release/adaptive-biotechnologies-launches-national-clinical-trial-to-develop-novel-t-cell
https://www.nasdaq.com/press-release/adaptive-biotechnologies-announces-pricing-of-public-offering-of-common-stock-2020-07
https://www.nasdaq.com/press-release/adaptive-biotechnologies-announces-proposed-public-offering-of-common-stock-2020-07
https://www.nasdaq.com/press-release/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-10-2020
https://www.nasdaq.com/press-release/update-adaptive-biotechnologies-to-participate-in-upcoming-june-investor-conferences
https://www.nasdaq.com/press-release/adaptive-biotechnologies-to-participate-in-upcoming-june-investor-conferences-2020-05
https://www.nasdaq.com/press-release/adaptive-biotechnologies-reports-first-quarter-2020-financial-results-2020-05-12
https://www.nasdaq.com/press-release/adaptive-biotechnologies-to-present-at-the-bofa-securities-2020-healthcare-conference
https://www.nasdaq.com/press-release/adaptive-biotechnologies-to-report-first-quarter-financial-results-on-may-12-2020
https://www.nasdaq.com/press-release/adaptive-biotechnologies-expands-executive-leadership-team-to-support-development-and
https://www.nasdaq.com/press-release/adaptive-biotechnologies-reports-fourth-quarter-and-full-year-2019-financial-results
https://www.nasdaq.com/press-release/adaptive-biotechnologies-to-present-at-the-40th-annual-cowen-health-care-conference
https://www.nasdaq.com/press-release/adaptive-biotechnologies-to-report-fourth-quarter-and-full-year-2019-financial
https://www.nasdaq.com/press-release/adaptive-announces-pricing-of-public-offering-of-common-stock-2020-01-23
https://www.nasdaq.com/press-release/adaptive-announces-proposed-public-offering-of-common-stock-2020-01-21
https://www.nasdaq.com/press-release/adaptive-announces-preliminary-unaudited-revenue-for-full-year-2019-2020-01-21
https://www.nasdaq.com/press-release/adaptive-and-genentech-partner-to-use-clonoseqr-assay-to-measure-minimal-residual
https://www.nasdaq.com/press-release/adaptive-biotechnologies-receives-expanded-medicare-coverage-of-clonoseqr-for
https://www.nasdaq.com/press-release/adaptive-biotechnologies-to-present-at-the-38th-annual-j.p.-morgan-healthcare
https://www.nasdaq.com/press-release/adaptive-and-abbvie-partner-across-multiple-myeloma-trials-to-measure-minimal
https://www.nasdaq.com/press-release/adaptive-biotechnologies-and-collaborators-to-present-data-from-more-than-25
https://www.nasdaq.com/press-release/adaptive-biotechnologies-corporation-reports-third-quarter-2019-financial-results
https://www.nasdaq.com/press-release/adaptive-biotechnologies-to-report-third-quarter-financial-results-on-november-12
